Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD

Fig. 2

Survival Curves of high and low expression of FNBP1 in different cancers from the PrognoScan. A OS (n = 77) in brain cancer cohort GSE4271-GPL96. B OS (n = 74) in brain cancer cohort GSE4412-GPL96. C RFS (n = 87) in breast cancer cohort GSE6532-GPL570. D DMFS (n = 87) in breast cancer cohort GSE6532-GPL570. E OS (n = 159) in breast cancer cohort GSE1456-GPL96. F DSS (n = 159) in breast cancer cohort GSE1456-GPL96. G RFS (n = 159) in breast cancer cohort GSE1456-GPL97. H DMFS (n = 286) in breast cancer cohort GSE2034. I RFS (n = 77) in breast cancer cohort GSE9195. J DMFS (n = 77) in breast cancer cohort GSE9195. K DMFS (n = 200) in breast cancer cohort GSE11121. L DFS (n = 76) in breast cancer cohort GSE7849. M DSS (n = 236) in breast cancer cohort GSE3494-GPL96. N DFS (n = 249) in breast cancer cohort GSE4922-GPL97. O OS (n = 180) in blood cancer cohort GSE16131-GPL96. P DSS (n = 559) in blood cancer cohort GSE2658. Q OS (n = 55) in colorectal cancer cohort GSE17537. R RFS (n = 204) in lung cancer cohort GSE31210. S OS (n = 133) in ovarian cancer cohort DUKE-OC. T OS (n = 38) in skin cancer cohort GSE19234. OS, overall survival; DMFS, distant metastasis-free survival; DFS, disease-free survival; RFS, relapse-free survival

Back to article page